Table 3.
A list of AP clinical trials studies.
Studies | Trial ID | Mechanism of action | Clinical Phases/Study design |
Chemotherapy-induced Oral Mucositis | NCT04317183 | Topical chamomile oral gel may affect the prevention of chemotherapy-induced oral mucositis | Recruiting/Phase 2 |
Diabetes Mellitus Type 2 | NCT04233658 | Chlorogenic acid, luteolin and AP can be improved antidiabetic effects through downregulation of gluconeogenesis. | Phase 3 |
Pancreatic Cancer | NCT00609310 | The effect of AP on GLUT-1, HIF and VEGF prevents the proliferation of PC cells | Suspended/Phase 2 |
COVID | NCT04404218 | The use of natural extracts such as AP to diminution inflammation in patients with SARS-COV-2 | Recruiting/ Phase 2 |
Cardiovascular Risk (NUT) | NCT04114916 | Changes in the dilatation of the Humeral artery | Completed |
Allergic Rhino Conjunctivitis | NCT03365648 | The use of rosmarinic acid, AP, luteolin and chrysoeriol can be prevent the release of histamine and interleukins | Completed |